Cancer-associated fibroblasts can reduce the activation of various immune effector cells, such as cytotoxic CD8+ T cells and natural killer (NK) cells, by expressing immune checkpoints inhibitory molecules such as programmed death ligands PD-L1, PD-L2, and anti-cytotoxic T lymphocyte-associated protein 4 CTLA-4 [67]. Here, PDCD1LG2 is linked to cancer.